艾昆纬
IQV
查看详细走势图
229.652USD
-5.968-2.53%
交易中 （美东）报价延迟15分钟
39.11B总市值
31.31市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
-2.53%
5天
-3.93%
1月
+1.12%
6月
+18.04%
今年开始到现在
+1.88%
1年
+15.95%
查看详细走势图
TradingKey 艾昆纬股票评分
单位: USD 更新时间: 2026-01-29操作建议
艾昆纬当前公司基本面数据相对稳定，增长潜力很大。当前估值合理，在生物技术与医疗研究行业排名3/393位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价260.17。中期看，股价处于平稳状态。近一个月，市场表现一般，但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
艾昆纬评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
中性
艾昆纬亮点
亮点风险
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
行业龙头
公司营业收入处于行业前列，最新年度总收入15.40B美元
利润高增长
公司净利润处于行业前列，最新年度总收入15.40B美元
估值合理
公司最新PE估值32.12，处于3年历史合理位
机构减仓
最新机构持股169.60M股，环比减少9.58%
CI 精选加拿大股票基金持仓
明星投资者CI 精选加拿大股票基金持仓，最新持仓市值3.52K
活跃度降低
近期活跃度降低，过去20天平均换手率-0.10
分析师目标
根据
25
位分析师
买入
评级
260.169
目标均价
+7.94%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
艾昆纬新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
艾昆纬简介
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
公司代码IQV
公司艾昆纬
CEOBousbib (Ari)
网址https://ir.iqvia.com/
相关品种
